James Smith

Business Development Associate

James is a DPhil (PhD) researcher working on predicting the regulatory approval of early stage medicines using machine learning, and on improving IP landscaping practices. He has experience working as a consultant on a range of early stage biotech and medtech asset-focussed projects. Prior to his DPhil, James was a research scholar at the Harvard Stem Cell Institute, and completed his undergraduate degree in Biological Sciences at Oxford.

Other team Members

Dr Nicholas Ibery

View profile

Professor Eric Yeatman

View profile

Dr Paul Varley

View profile

Victoria Carr

Senior Advisor

View profile

Dr Ajoeb Baridi

Deputy CEO, Innovation Forum

View profile
We use cookies to ensure that we give you the best tailored experience on our website based on your preferences. By continuing to use our services, you are giving us your consent to use cookies. Learn more here.